EU Systemic Lupus Erythematosus Market, Market Segmented by Drug type (Immunosuppressants, Biologics, Antimalarials, NSAIDs, Corticosteroids) and by Route of Administration (Oral, Intravenous and Subcutaneous)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138217
- Pages: 200
-
Format:
Report Overview
The EU Systemic Lupus Erythematosus Market size stood at around USD xx billion in 2019 and is projected to reach USD $0.4 billion by 2028, exhibiting a CAGR of xx% during the forecast period
Systemic lupus erythematosus (SLE) is the chronic, autoimmune disorder which involves multiple organ-systems such as heart, kidney, skin, joints, blood, lungs and, in most severe cases, brain. In this disease, the human immune system becomes hyperactive and attacks the normal, healthy tissues of the body. Women from the Asian, Afro-Caribbean and Hispanic descent are chiefly affected by this disease
Market Drivers
Market drivers and restraints for Systemic Lupus Erythematosus are, drugs market would grow prominently due to factors such as rising incidences of SLE, increasing R&D investment on SLE drugs, and rising ageing population. Factors restraining the market growth are increasing drugs prices and presence of stringent regulatory environment
1. EU Systemic Lupus Erythematosus Market Overview
A. Market Size
2. EU Systemic Lupus Erythematosus Market Growth Drivers and Market Restraints.
A. Rising incidences of SLE, increasing R&D investment on SLE drugs, and rising ageing population
B. Increasing drugs prices and presence of stringent regulatory environment
3. EU Systemic Lupus Erythematosus Market Segmentation
A. By Drug Type
I. Immunosuppressants
II. Biologics
III. Antimalarials
IV. NSAIDS
V. Corticosteroids
B. By Route of Administration
I. Oral
II. Intravenous
III. Subcutaneous
4. EU Systemic Lupus Erythematosus Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. GlaxoSmithKline Plc, Company overview, Product & Services, Strategies & Financials
B. Pfizer Ltd, Company overview, Product & Services, Strategies & Financials
C. Immunopharma Plc, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
